Drug Type Proteolysis-targeting chimeras (PROTAC) |
Synonyms SJ000988498 |
Target |
Mechanism JAK2 inhibitors(Tyrosine-protein kinase JAK2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC35H34N10O5 |
InChIKeyDEVPPEULDFALCD-UHFFFAOYSA-N |
CAS Registry- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 10 May 2021 | |
Rheumatoid Arthritis | Preclinical | US | 10 May 2021 |